Awareness, treatment rates, and compliance to treatment in patients with serum LDL cholesterol higher than 250 mg/dL, and possible, probable, or definite familial hypercholesterolemia

References

• Soutar AK, Naoumova RP. Mechanism of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med. 2007;4:214–225.
   PubMedGoogle Scholar
• Hovingh GK, Davidson MH, Kastelein JJP, et al. Diagnosis and treatment of familial hypercholesterolemia. Eur Heart J. 2013;34:962–971.
   PubMed Web of Science ®Google Scholar
• Kavey RE, Allada V, Daniels SR, et al. American Heart Association Expert Panel on Population and Prevention Science; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Nutrition, Physical Activity and Metabolism; American Heart Association Council on High Blood Pressure Research; American Heart Association Council on Cardiovascular Nursing; American Heart Association Council on the Kidney in Heart Disease; Interdisciplinary Working Group on Quality of Care and Outcomes Research. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Actvity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2006;114((24.):2710–2738.
   PubMed Web of Science ®Google Scholar
• Civeria F. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis. 2004;173:55–68.
   PubMed Web of Science ®Google Scholar
• Williams RR, Hunt SC, Schumacher MC, et al. Diagnosis heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol. 1993;72:171–176.
   PubMed Web of Science ®Google Scholar
• Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolemia. BMJ. 1991;303(6807):893–896. DOI: 10.1136/bmj.303.6807.893.
   Google Scholar
• Nordestgaard BG, Chapman MJ, Humphries SE, et al. European Atherosclerosis Society Consensus Panel: familial Consensus Statement of the European Atherosclerosis Society. Hypercholesterolemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease. Eur Heart J. 2013;34(45):3478–3490.
   PubMed Web of Science ®Google Scholar
• Safarova MS, Liu H, Kullo IJ. Rapid identification of familial hypercholesterolemia from electronic health records: the SEARCH study. J Clin Lipidol. 2016;10(5):1230–1239.
   PubMed Web of Science ®Google Scholar
• Ahmad ZS, Andersen RL, Andersen LH, et al. US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry. J Clin Lipidol. 2016;10(5):1223–1229.
   PubMed Web of Science ®Google Scholar
• Neil HA, Hammond T, Huxley R, et al. Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study. BMJ. 2000;321(7254):148.
   PubMedGoogle Scholar
• deGoma EM, Ahmad ZS, O’Brien EC, et al. Treatment gaps in adults with heterozygous familial hypercholesterolemia in the United States data from the CASCADE-FH registry. Circ Cardiovasc Genet. 2016;9:240–249.
   PubMed Web of Science ®Google Scholar
• Brunham LR, Cermakova L, Lee T, et al. Contemporary trends in the management and outcomes of patients with familial hypercholesterolemia in Canada: a prospective observational study. Can J Cardiol. 2017;33:385–392.
   PubMed Web of Science ®Google Scholar
• Bucholz EM, Rodday AM, Kolor K, et al. Prevalence and predictors of cholesterol screening, awareness, and statin treatment among US adults with familial hypercholesterolemia or other forms of severe dyslipidemia (1999-2014). Circulation. 2018;137(21):2218–2230.
   PubMed Web of Science ®Google Scholar
• Batais MA, Almigbal TH, Abdulhak AAB, et al. Assessment of physicians’ awareness and knowledge of familial hypercholesterolemia in Saudi Arabia: is there a gap? PLoS ONE. 2017;12(8):e0183494.
   PubMed Web of Science ®Google Scholar
• Bell DA, Garton-Smith J, Vickery A, et al. Familial hypercholesterolaemia in primary care: knowledge and practices among general practitioners in Western Australia. Heart Lung Circ. 2014;23(4):309–313. .
   PubMed Web of Science ®Google Scholar
• Rangarajan N, Balasubramanian S, Pang J, et al. Knowledge and awareness of familial hypercholesterolaemia among registered medical practitioners in Tamil Nadu: are they suboptimal? J Clin Diagn Res. 2016;10(5):OC52–56.
   PubMed Web of Science ®Google Scholar
• Kwok S, Pang J, Adam S, et al. An online questionnaire survey of UK general practitioners’ knowledge and management of familial hypercholesterolaemia. BMJ Open. 2016;6(11):e012691.
   PubMed Web of Science ®Google Scholar
• Benn M, Watts GF, Tybjaerg-Hansen A, et al. Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab. 2012;97(11):3956–3964.
   PubMed Web of Science ®Google Scholar
• Besseling J, Sjouke B, Kastelein JJ. Screening and treatment of familial hypercholesterolemia - Lessons from the past and opportunities for the future (based on the Anitschkow Lecture 2014). Atherosclerosis. 2015;241(2):597–606.
   PubMed Web of Science ®Google Scholar
• Turkey Family Structure Research Findings, Recommendations. T. C. Ministry of Family and Social Policies. Research and Social Policy Series 07. Türkiye Aile Yapısı Araştırması Tespitler, Öneriler. T.C. Aile ve Sosyal Politikalar Bakanlığı. Araştırma ve Sosyal Politika Serisi 07. İstanbul: Çizge Tanıtım ve Kırtasiye Ltd. Şti. Birinci Basım; 2014. ISBN: 978-605-4628-55-1. .[cited 2020 Mar 23]. Available from: https://ailevecalisma.gov.tr
   Google Scholar
• Haymana C, Berlik H, Güneş Y, et al. Identifying undiagnosed or undertreated patients with familial hypercholesterolemia from the laboratory records of a tertiary medical center. Turk Kardiyol Dern Ars. 2017;45(8):731–738.
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497.
   PubMed Web of Science ®Google Scholar
• Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA. 1990;264:3018–3024.
   PubMed Web of Science ®Google Scholar
• Nanchen D, Gencer B, Muller O, et al. Prognosis of patients with familial hypercholesterolemia after acute coronary syndromes. Circulation. 2016;134(10):698–709.
   PubMed Web of Science ®Google Scholar
• Onat A, Senocak M, Surdum-Avcı G, et al. Prevalence of disease in population with low cholesterol levels. Int J Cardiol coronary heart disease in Turkish adults. Int J Cardiol. 1993;39:23–31.
   PubMedGoogle Scholar
• Satman I, Omer B, Tutuncu Y, et al. TURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28(2):169–180.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. Diabetes Atlas. 8th ed. 2017. cited 2020 Mar 23]. Available from: http://www.diabetesatlas.org/resources/2017-atlas.html
   Google Scholar
• Umans-Eckenhausen MA, Defesche JC, Sijbrands EJ, et al. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet. 2001;357:165–168.
   PubMed Web of Science ®Google Scholar
• Humphries SE, Norbury G, Leigh S, et al. What is the clinical utility of DNA testing in patients with familial hypercholesterolaemia? Curr Opin Lipidol. 2008;19:362–368.
   PubMed Web of Science ®Google Scholar
• Bhatnagar D, Morgan J, Siddiq S, et al. Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia. BMJ. 2000;321:1497–1500.
   PubMed Web of Science ®Google Scholar